TD Cowen Raises Boston Scientific Corporation (BSX) Target to $115, Reaffirms ‘Buy’ Rating Ahead of Q4 Results
As the global AI race heated up last month with the launch of DeepSeek R1 and Alibaba’s Qwen 2.5 AI models, US AI firms are ...
Boston Scientific price target raised to $115 from $110 at TD Cowen
TD Cowen raised the firm’s price target on Boston Scientific (BSX) to $115 from $110 and keeps a Buy rating on the shares. The firm expects ...
Boston Scientific price target raised to $115 from $95 at Piper Sandler
Piper Sandler analyst Matt O’Brien raised the firm’s price target on Boston Scientific (BSX) to $115 from $95 and keeps an Overweight rating on ...
Hosted on MSN12h
Is Wall Street Bullish or Bearish on Boston Scientific Stock?
Commanding a market cap of $150.9 billion, Boston Scientific Corporation (BSX) is a global medical device manufacturer that ...